Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company ...

Globus Medical and NuVasive's merger marked its first year on Sept. 1, Globus' CEO Dan Scavilla said in a Nov. 5 earnings call.

Globus Medical, Inc.’s GMED merger with NuVasive is expected to generate significant synergies, enhance its globalization initiatives, expand customer access and bolster ties with surgeons. The ...

Globus Medical, Inc.'s stock has surged due to a successful execution of the NuVasive deal and three consecutive guidance hikes, boosting investor confidence and valuation. The $3.1 billion ...

The stock carries a Zacks Rank #2 (Buy) currently. Globus Medical merged its business with NuVasive. The combined company has formed a global musculoskeletal company focused on rapid innovation ...